Your browser doesn't support javascript.
loading
MicroRNAs and Target Genes in Pituitary Adenomas.
Feng, Yajuan; Mao, Zhi-Gang; Wang, Xin; Du, Qiu; Jian, Mengyao; Zhu, Dimin; Xiao, Zheng; Wang, Hai-Jun; Zhu, Yong-Hong.
Affiliation
  • Feng Y; Department of Histology and Embryology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong Province, China.
  • Mao ZG; Department of Neurosurgery and Pituitary Tumor Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong Province, China.
  • Wang X; Department of Histology and Embryology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong Province, China.
  • Du Q; Department of Histology and Embryology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong Province, China.
  • Jian M; Department of Histology and Embryology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong Province, China.
  • Zhu D; Department of Neurosurgery and Pituitary Tumor Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong Province, China.
  • Xiao Z; Department of Neurosurgery and Pituitary Tumor Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong Province, China.
  • Wang HJ; Department of Neurosurgery and Pituitary Tumor Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong Province, China.
  • Zhu YH; Department of Histology and Embryology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong Province, China.
Horm Metab Res ; 50(3): 179-192, 2018 03.
Article in En | MEDLINE | ID: mdl-29351706
ABSTRACT
Pituitary adenomas account for the top three primary intracranial tumors in terms of total incidence rates. The clinical symptoms presented by the disease are often characterized by a series of systemic endocrine disorders, severe occupational lesions, and even some malignant features, and therefore early diagnosis and predicting recurrence would be instructive for clinical treatment of pituitary adenomas. An increasing number of specific microRNA (miRNA) expression signatures have been identified in pituitary, and miRNAs are related with the pituitary tumorigenesis, dysfunction, neurodegeneration, and metastatic non-functioning pituitary carcinoma. Here, this paper reviews the effects of aberrant miRNA expression in human pituitary adenomas and summarizes some corresponding target genes and biological significance over the last 7 years (2010-2017).
Subject(s)

Full text: 1 Database: MEDLINE Main subject: Pituitary Neoplasms / Adenoma / Gene Expression Regulation, Neoplastic / MicroRNAs Type of study: Screening_studies Limits: Humans Language: En Journal: Horm Metab Res Year: 2018 Type: Article Affiliation country: China

Full text: 1 Database: MEDLINE Main subject: Pituitary Neoplasms / Adenoma / Gene Expression Regulation, Neoplastic / MicroRNAs Type of study: Screening_studies Limits: Humans Language: En Journal: Horm Metab Res Year: 2018 Type: Article Affiliation country: China